2012
DOI: 10.1227/neu.0b013e3182417bc2
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Mannitol on Cerebral Blood Volume in Patients With Head Injury

Abstract: Background Mannitol has traditionally been the mainstay of medical therapy for intracranial hypertension in patients with head injury. We previously demonstrated that mannitol reduces brain volume in patients with cerebral edema, although whether this occurs due to a reduction in brain water, blood volume or both remains poorly understood. Objective To test the hypothesis that mannitol acts by lowering blood viscosity leading to reflex vasoconstriction and a fall in cerebral blood volume (CBV). Methods We … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
16
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 35 publications
(17 citation statements)
references
References 20 publications
0
16
0
Order By: Relevance
“…Out of the 11 patients who were operated in our patient group, whose GSC scores were below 8, only four of the seven patients lying longer than seven days had an outflow scoreHyperosmolar treatments remain as a therapeutic option in intracranial hypertension. The intracranial pressure-reducing effect of mannitol is thought to reduce direct brain edema [11] .…”
Section: Discussionmentioning
confidence: 99%
“…Out of the 11 patients who were operated in our patient group, whose GSC scores were below 8, only four of the seven patients lying longer than seven days had an outflow scoreHyperosmolar treatments remain as a therapeutic option in intracranial hypertension. The intracranial pressure-reducing effect of mannitol is thought to reduce direct brain edema [11] .…”
Section: Discussionmentioning
confidence: 99%
“…Hyperglycemia also stimulates release of proinflammatory mediators, such as, IL-1β, IL-6, TNF-α, and TGF-β, and production of reactive oxygen species (ROS) by immune cells, worsening neurological outcomes (Kumar & Loane, 2012; Shi et al, 2016). In addition, hyperglycemia damages the blood–brain barrier and increases blood viscosity, which reduces flow velocity and increase tendency for thrombosis (Chesnut, 2007; Diringer et al, 2012).…”
Section: Discussionmentioning
confidence: 99%
“…Bolus intravenous administration of mannitol to reduce ICH does not acutely lower CBV. 213 These studies provide evidence for an alternative mechanism-acute reduction of brain water-to explain the effect of mannitol. Another study examined the effect of tight (80-110 mg/dL) versus loose (120-150 mg/dL) glycemic control, using both FDG PET and microdialysis.…”
mentioning
confidence: 86%